These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21896895)

  • 1. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.
    Dandona P; Dhindsa S
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2643-51. PubMed ID: 21896895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
    Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadotropic Hypogonadism in Men With Diabesity.
    Dhindsa S; Ghanim H; Batra M; Dandona P
    Diabetes Care; 2018 Jul; 41(7):1516-1525. PubMed ID: 29934480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease.
    Dhindsa S; Reddy A; Karam JS; Bilkis S; Chaurasia A; Mehta A; Raja KP; Batra M; Dandona P
    Eur J Endocrinol; 2015 Sep; 173(3):359-66. PubMed ID: 26101371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P;
    J Sex Med; 2014 Mar; 11(3):840-56. PubMed ID: 24308723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild Hypogonadotropic hypogonadism in obese men.
    Strain GW; Zumoff B; Kream J; Strain JJ; Deucher R; Rosenfeld RS; Levin J; Fukushima DK
    Metabolism; 1982 Sep; 31(9):871-5. PubMed ID: 6811834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadotrophic hypogonadism in type 2 diabetes.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
    Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
    Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
    Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?
    Tripathy D; Dhindsa S; Garg R; Khaishagi A; Syed T; Dandona P
    Metab Syndr Relat Disord; 2003 Mar; 1(1):75-80. PubMed ID: 18370627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.
    Kapoor D; Channer KS; Jones TH
    Diab Vasc Dis Res; 2008 Jun; 5(2):135-7. PubMed ID: 18537102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation Between Testosterone and Metabolic Index in Male Patients with Type 2 Diabetes Mellitus].
    Cao W; Zheng RD; Fan YF; Liu C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):235-238. PubMed ID: 29737067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
    Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone concentration in young patients with diabetes.
    Chandel A; Dhindsa S; Topiwala S; Chaudhuri A; Dandona P
    Diabetes Care; 2008 Oct; 31(10):2013-7. PubMed ID: 18650372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.